drugset / Trial / NCT01292668

Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer

NCT01292668

RandomizedParallel-groupOpen-labelTreatment

Summary

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, cancer cells are killed. Photodynamic therapy using methyl-5-aminolevulinate hydrochloride cream may be effective against skin cancer. PURPOSE: This phase I trial is studying the side effects and best dose of photodynamic therapy with methyl-5-aminolevulinate hydrochloride cream in determining pain threshold patients with skin cancer

Timeline

Start
2011-03
Primary completion
2012-07
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject methyl aminolevulinate Small molecule Topical